Massmutual Trust CO Fsb Trevi Therapeutics, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.87 Billion
- Q3 2025
A detailed history of Massmutual Trust CO Fsb transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 516 shares of TRVI stock, worth $5,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
516
Previous 528
2.27%
Holding current value
$5,944
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRVI
# of Institutions
166Shares Held
111MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$152 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$118 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$98.3 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$61.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$51.7 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $672M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...